[DPHARMA] YoY Cumulative Quarter Result on 30-Sep-2017 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
17-Nov-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
30-Sep-2017 [#3]
Profit Trend
QoQ- 59.35%
YoY- 62.3%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 435,816 438,707 383,088 355,734 238,907 181,279 125,937 22.96%
PBT 55,686 56,870 42,008 38,971 25,180 32,226 32,589 9.33%
Tax -13,269 -13,630 -8,736 -8,639 -7,185 -8,786 -8,014 8.75%
NP 42,417 43,240 33,272 30,332 17,995 23,440 24,575 9.51%
-
NP to SH 42,417 43,240 33,272 30,622 18,867 23,440 24,575 9.51%
-
Tax Rate 23.83% 23.97% 20.80% 22.17% 28.53% 27.26% 24.59% -
Total Cost 393,399 395,467 349,816 325,402 220,912 157,839 101,362 25.33%
-
Net Worth 584,565 505,919 501,487 474,230 451,913 268,509 187,436 20.85%
Dividend
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Div 3,479 6,745 9,897 - - - 5,553 -7.49%
Div Payout % 8.20% 15.60% 29.75% - - - 22.60% -
Equity
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Net Worth 584,565 505,919 501,487 474,230 451,913 268,509 187,436 20.85%
NOSH 706,026 680,106 661,881 278,959 278,959 278,959 138,841 31.10%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin 9.73% 9.86% 8.69% 8.53% 7.53% 12.93% 19.51% -
ROE 7.26% 8.55% 6.63% 6.46% 4.17% 8.73% 13.11% -
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
RPS 62.63 65.04 58.06 127.52 85.64 108.70 90.71 -5.98%
EPS 6.16 6.49 5.09 10.87 6.45 14.04 17.70 -16.11%
DPS 0.50 1.00 1.50 0.00 0.00 0.00 4.00 -29.26%
NAPS 0.84 0.75 0.76 1.70 1.62 1.61 1.35 -7.59%
Adjusted Per Share Value based on latest NOSH - 278,959
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
RPS 45.31 45.61 39.82 36.98 24.84 18.85 13.09 22.96%
EPS 4.41 4.50 3.46 3.18 1.96 2.44 2.55 9.55%
DPS 0.36 0.70 1.03 0.00 0.00 0.00 0.58 -7.63%
NAPS 0.6077 0.5259 0.5213 0.493 0.4698 0.2791 0.1949 20.84%
Price Multiplier on Financial Quarter End Date
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Date 30/09/20 30/09/19 28/09/18 29/09/17 30/09/16 30/09/15 30/09/14 -
Price 3.16 1.40 1.23 2.20 2.06 2.72 3.17 -
P/RPS 5.05 2.15 2.12 1.73 2.41 2.50 3.49 6.34%
P/EPS 51.84 21.84 24.39 20.04 30.46 19.35 17.91 19.35%
EY 1.93 4.58 4.10 4.99 3.28 5.17 5.58 -16.20%
DY 0.16 0.71 1.22 0.00 0.00 0.00 1.26 -29.08%
P/NAPS 3.76 1.87 1.62 1.29 1.27 1.69 2.35 8.14%
Price Multiplier on Announcement Date
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Date 12/11/20 29/11/19 28/11/18 17/11/17 21/11/16 24/11/15 21/11/14 -
Price 4.04 1.39 1.07 2.20 2.10 2.70 3.01 -
P/RPS 6.45 2.14 1.84 1.73 2.45 2.48 3.32 11.69%
P/EPS 66.28 21.68 21.22 20.04 31.05 19.21 17.01 25.41%
EY 1.51 4.61 4.71 4.99 3.22 5.21 5.88 -20.25%
DY 0.12 0.72 1.40 0.00 0.00 0.00 1.33 -33.00%
P/NAPS 4.81 1.85 1.41 1.29 1.30 1.68 2.23 13.65%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment